Skip to main content

Advertisement

Log in

Pattern of systemic lupus erythematosus in NIGERIA: a multicentre descriptive hospital-based study

  • ORIGINAL ARTICLE
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Introduction

Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease with manifestations ranging from mild to life-threatening organ dysfunction. There is wide variability in the reported incidence and prevalence rate globally, particularly in low and middle-income countries. Nigeria had very few isolated reports of SLE from private and public hospitals Therefore, we conducted this large multi-center descriptive study to determine the sociodemographic, clinical profile, laboratory patterns, and treatment among Nigerian lupus patients.

Methods

A retrospective hospital-based study of all SLE patients seen over 4 years (January 2017 to December 2020) was conducted at 20 rheumatology clinics spread across the 6 geopolitical zones of Nigeria. All patients 18 years and above satisfying the American College of Rheumatology (ACR) 1997 and/or the Systemic Lupus International Collaboration Clinics (SLICC) 2012 classification criteria for SLE were enrolled. Patients with other Rheumatic and Musculoskeletal Diseases (RMDs) not in keeping with SLE and Patients with incomplete data were excluded. Data was analysed using SPSS version 23.0 software.

Results

A total of 896 patients with SLE were included in the final analysis with a mean age ± SD of 34.47 ± 11 and a female to male ratio of 8.1:1. Synovitis was reported by 61.6% of patients, while 51%, 19.9% and11.4% patients reported acute, sub-acute and chronic lupus rashes respectively. ANA was positive in 98.0% with titers ranging from 1:80 to 1:64,000.

Conclusion

SLE is not rare in Nigeria. Most patients were female in their 3rd to 4th decades of life. There is a delayed presentation to a rheumatology facility. Arthritis and mucocutaneous manifestations were the most frequent presentation.

Key Points

This study presents the first national data on SLE in Nigeria

This study showed that SLE is not rare in Nigeria in contrast to previous reports

There appear to be ethnic disparity in the frequency of lupus among Nigerians

Nigerians with lupus have very high titer of ANA

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

Data can be provided on request and after approval by all authors.

References

  1. World Lupus Federation (2020) World Lupus Federation Global Survey 2020- Finds lupus greatly impacts physical function and quality of life. https://worldlupusfederation.org/2020/05/07/world-lupus-federation-global-survey-2020-topline-summary/ Accessed 21 February 2022

  2. Barber MRW, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow NY, Svenungsson E, Peterson J, Clarke AE, Ramsey-Goldman R (2021) Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol 17:515–532. https://doi.org/10.1038/s41584-021-00668-1

    Article  PubMed  PubMed Central  Google Scholar 

  3. Fatoye F, Gebrye T, Mbada C (2022) Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle-income countries: a systematic review and meta-analysis. Rheumatol Int. https://doi.org/10.1007/s00296-022-05183-4

    Article  PubMed  PubMed Central  Google Scholar 

  4. Essouma M, Nkeck JR, Endomba FT, Bigna JJ, Singwe-Ngandeu M, Hachulla E (2020) Systemic lupus erythematosus in Native sub-Saharan Africans: A systematic review and meta-analysis. J Autoimmun. https://doi.org/10.1016/j.jaut.2019.102348

    Article  PubMed  Google Scholar 

  5. Adelowo O, Mody GM, Tikly M, Oyoo O, Slimani S (2021) Rheumatic diseases in Africa. Nat Rev Rheumatol 17:363–374. https://doi.org/10.1038/s41584-021-00603-4

    Article  PubMed  PubMed Central  Google Scholar 

  6. Adelowo OO, Ojo O, Oduenyi I, Okwara CC (2010) Rheumatoid arthritis among Nigerians: the first 200 patients from a rheumatology clinic. Clin Rheumatol 29:593–597

    Article  PubMed  Google Scholar 

  7. Emorinken A, Dic-Ijiewere MO, Erameh CO, Ugheoke AJ, Agbadaola OR, Agbebaku FO (2021) Clinical and laboratory profile of systemic lupus erythematosus patients at a rural tertiary centre in South-South Nigeria: experience from a new rheumatology clinic. Reumatologia 59:402–410. https://doi.org/10.5114/reum.2021.111714

    Article  PubMed  PubMed Central  Google Scholar 

  8. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725. https://doi.org/10.1002/art.1780400928

    Article  CAS  PubMed  Google Scholar 

  9. Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686. https://doi.org/10.1002/art.34473

    Article  PubMed  PubMed Central  Google Scholar 

  10. Markowitz GS, D’Agati VD (2007) The ISN/RPS 2003 classification of lupus nephritis: an assessment at 3 years. Kidney Int 71:491–495. https://doi.org/10.1038/sj.ki.5002118

    Article  CAS  PubMed  Google Scholar 

  11. Khanfir MS, Houman MH, Cherif E, Hamzaoui A, Souissi S, Ben Ghorbel I et al (2013) TULUP (TUnisian LUPus): a multicentric study of systemic lupus erythematosus in Tunisia. Int J Rheum Dis 16:539–546

    Article  PubMed  Google Scholar 

  12. El Hadidi KT, Medhat BM, Abdel Baki NM, Abdel Kafy H, Abdelrahaman W, Yousri AY et al (2018) Characteristics of systemic lupus erythematosus in a sample of the Egyptian population: a retrospective cohort of 1109 patients from a single center. Lupus 27:1030–1038

    Article  PubMed  Google Scholar 

  13. Budhoo A, Mody GM, Dubula T, Patel N, Mody PG (2017) Comparison of ethnicity, gender, age of onset and outcome in South Africans with systemic lupus erythematosus. Lupus 26:438–446

    Article  CAS  PubMed  Google Scholar 

  14. Adelowo OO, Ojo O, Oduenyi I (2012) Autoantibodies in Nigerian lupus patients. Afr J Med Sci 41:177–181

    CAS  Google Scholar 

  15. Symmons DP (1995) Frequency of lupus in people of African origin. Lupus 4:176–178

    Article  CAS  PubMed  Google Scholar 

  16. Bae SC, Fraser P, Liang MH (1998) The epidemiology of systemic lupus erythematosus in populations of African ancestry: a critical review of the “prevalence gradient hypothesis.” Arthritis Rheum 41:2091–2099

    Article  CAS  PubMed  Google Scholar 

  17. Adwan M (2018) Clinical and Serologic Characteristics of Systemic Lupus Erythematosus in the Arab World: A Pooled Analysis of 3,273 Patients. Arch Rheumatol 33:455–463

    Article  PubMed  PubMed Central  Google Scholar 

  18. Li M, Wang Y, Zhao J, Wang Q, Wang Z, Tian X, Zeng X (2021) Chinese SLE Treatment and Research Group (CSTAR) Registry 2009–2019: major clinical characteristics of Chinese patients with systemic lupus erythematosus. Rheumatol Immunol Res 2:43–47

    Article  PubMed  PubMed Central  Google Scholar 

  19. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P et al (1993) Systemic lupus erythematosus:clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European working party on systemic lupus erythematosus. Medicine (Baltimore) 72:113–124

    Article  CAS  PubMed  Google Scholar 

  20. Pons-Estel BA, Catoggio LJ, Cardiel MH, Soriano ER, Gentiletti S, Villa AR et al (2004) The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among “Hispanics.” Medicine (Baltimore) 83:1–17. https://doi.org/10.1097/01.md.0000104742.42401.e2

    Article  PubMed  Google Scholar 

  21. Maningding E, Dall’Era M, Trupin L, Murphy LB, Yazdany J (2020) Racial and ethnic differences in the prevalence and time to onset of manifestations of systemic lupus erythematosus: the California lupus surveillance project. Arthritis Care Res (Hoboken) 72:622–629

    Article  PubMed  Google Scholar 

  22. Gergianaki I, Garantziotis P, Adamichou C, Saridakis I, Spyrou G, Sidiropoulos P, Bertsias G (2021) High comorbidity burden in patients with sle: data from the community-based lupus registry of crete. J Clin Med 10:998. https://doi.org/10.3390/jcm10050998

    Article  PubMed  PubMed Central  Google Scholar 

  23. Pryor KP, Barbhaiya M, Costenbader KH, Feldman CH (2020) Disparities in lupus and lupus nephritis care and outcomes among us medicaid beneficiaries. Rheum Dis Clin North Am 47:41–53. https://doi.org/10.1016/j.rdc.2020.09.004

    Article  PubMed  PubMed Central  Google Scholar 

  24. Elbagir S, Elshafie AI, Elagib EM, Mohammed NA, Aledrissy MIE, Sohrabian A et al (2020) Sudanese and Swedish patients with systemic lupus erythematosus: immunological and clinical comparisons. Rheumatology (Oxford) 59:968–978

    Article  PubMed  Google Scholar 

  25. Li H, Zheng Y, Chen L et al (2022) High titers of antinuclear antibody and the presence of multiple autoantibodies are highly suggestive of systemic lupus erythematosus. Sci Rep 12:1687. https://doi.org/10.1038/s41598-022-05807-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Han BK, Rathwell E, Ng B, Wener M (2018). Evaluation of Erythrocyte Sedimentation Rate As a Marker of Disease Activity in Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 70 (suppl 10). https://acrabstracts.org/abstract/evaluation-of-erythrocyte-sedimentation-rate-as-a-marker-of-disease-activity-in-patients-with-systemic-lupus-erythematosus/. Accessed 21 February 2022

  27. Akintayo RO, Akpabio AA, Kalla AA, Dey D, Migowa AN, Olaosebikan H et al (2021) The impact of COVID-19 on rheumatology practice across Africa. Rheumatology (Oxford) 60:392–398. https://doi.org/10.1093/rheumatology/keaa600

    Article  CAS  PubMed  Google Scholar 

  28. Shah R, Dey D, Pietzonka T, Obeng P, Ashiru B, Schiestl M, Cavey A, Nkansah E, Radiere G, Spector J, Scott C (2020) Determinants of use of biotherapeutics in sub-Saharan Africa. Trends Pharmacol Sci 42:75–84. https://doi.org/10.1016/j.tips.2020.11.012

    Article  CAS  PubMed  Google Scholar 

  29. Adelowo OO, Olisa O, Asekhame OT, Ojo O (2021) Biotherapies in medical practice: a review and the Nigerian experience. West Afr J Med 38:486–493

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We acknowledge the International League of Associations for Rheumatology (ILAR) Project 2020 for funding the LURIN.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Courage Ukponmwan Uhunmwangho.

Ethics declarations

Disclosures

None.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Osaze, O., Olaosebikan, H.B., Yerima, A. et al. Pattern of systemic lupus erythematosus in NIGERIA: a multicentre descriptive hospital-based study. Clin Rheumatol 42, 2787–2797 (2023). https://doi.org/10.1007/s10067-023-06672-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-023-06672-y

Keywords

Navigation